All Stories

  1. Transcranial magnetic stimulation for schizophrenia - a Cochrane review
  2. Patient factors associated with SSRI dose for depression treatment in general practice: a primary care cross sectional study
  3. Reducing patient delay with symptoms of acute coronary syndrome: a research protocol for a systematic review of previous interventions to investigate which behaviour change techniques are associated with effective interventions
  4. Deaths by suicide and their relationship with general and psychiatric hospital discharge: 30-year record linkage study
  5. The epidemiology of hospital treated traumatic brain injury in Scotland
  6. Consensus on items and quantities of clinical equipment required to deal with a mass casualties big bang incident: a national Delphi study
  7. Reviewing long-term antidepressants can reduce drug burden: a prospective observational cohort study
  8. Effect of attitudes to euthanasia on vets' suicide risk
  9. A SYSTEMATIC REVIEW AND META-ANALYSIS OF TMS FOR SCHIZOPHRENIA
  10. α4β2-Nicotinic Receptor Binding with 5-IA in Alzheimer’s Disease: Methods of Scan Analysis
  11. Cerebral Metabolism, Brain Imaging*
  12. Transcranial magnetic stimulation for schizophrenia
  13. Perfusion Imaging with Single Photon Emission Computed Tomography
  14. Functional imaging
  15. Global cognitive impairment should be taken into account in SPECT–neuropsychology correlations: the example of verbal memory in very mild Alzheimer’s disease
  16. Neuroimaging in Dementia
  17. Systematic Review of the Diagnostic Accuracy of 99mTc-HMPAO-SPECT in Dementia
  18. Systematic Review of the Diagnostic Accuracy of 99mTc-HMPAO-SPECT in Dementia
  19. Predicting the accuracy of a diagnosis of Alzheimer's disease with 99mTc HMPAO single photon emission computed tomography
  20. Brain Behaviour Relationships in Dementia (Neuropsychology)
  21. Voxel-Based Approaches in Clinical Imaging
  22. The Clinical Use of 99mTc-HMPAO-SPECT in Alzheimer�s Disease
  23. Statistical Parametric Mapping of 99mTc-HMPAO-SPECT Images for the Diagnosis of Alzheimer's Disease: Normalizing to Cerebellar Tracer Uptake
  24. A double-blind, placebo-controlled study of tacrine in patients with Alzheimer's disease using SPET
  25. The neuropsychiatric sequelae of mercury poisoning. The Mad Hatter's disease revisited
  26. Uptake of99mTc-exametazime shown by single photon emission computerized tomography in obsessive-compulsive disorder compared with major depression and normal controls
  27. PASAT performance and the pattern of uptake of 99mTc-exametazime in brain estimated with single photon emission tomography
  28. Regional cerebral blood flow in IDDM patients: Effects of diabetes and of recurrent severe hypoglycaemia
  29. Clonidine infusion increases uptake of 99mTc-Exametazime in anterior cingulate cortex in Korsakoff's psychosis
  30. Short-term effects of electroconvulsive treatment on the uptake of99mTc-Exametazime into brain in major depression shown with single photon emission tomography
  31. State changes in brain activity shown by the uptake of 99mTc-exametazime with single photon emission tomography in major depression before and after treatment
  32. A single photon emission computerised tomography study of regional brain function underlying verbal memory in patients with Alzheimer-type dementia
  33. A single photon emission computerised tomography study of regional brain function in elderly patients with major depression and with Alzheimer-type dementia
  34. The effect of anxiety induction on the regional uptake of 99mTc-Exametazime in simple phobia as shown by single photon emission tomography (SPET)
  35. Single-photon emission computed tomography with 99mTc-exametazime in unmediated schizophrenic patients
  36. Single photon emission tomography with 99mTc-exametazime in major depression and the pattern of brain activity underlying the psychotic/neurotic continuum
  37. SINGLE PHOTON EMISSION TOMOGRAPHY WITH 99MTC-EXAMETAZIME IN MAJOR DEPRESSION AND THE PATTERN OF BRAIN ACTIVITY UNDERLYING THE ENDOGENOUS/ NEUROTIC CONTINUUM
  38. EXAMETAZIME UPTAKE AFTER ECT: A SPET STUDY
  39. SPET WITH 99MTC-EXAMETAZIME: THE SPLIT DOSE TECHNIQUE AND PHARMACOLOGICAL ACTIVATION
  40. 99MTC-EXAMETAZIME SPECT IN UNMEDICATED PATIENTS WITH ACUTE NON-AFFECTIVE PSYCHOSIS
  41. Regional cerebral blood flow and cognitive function in patients with chronic liver disease